{
    "ticker": "ACST",
    "name": "Acasti Pharma Inc.",
    "description": "Acasti Pharma Inc. is a biopharmaceutical company focused on the development of innovative prescription drugs for the treatment of cardiovascular diseases and related conditions. Founded in 2002 and headquartered in Laval, Quebec, Canada, Acasti is dedicated to addressing the unmet medical needs of patients suffering from hypertriglyceridemia and other lipid disorders. The company is advancing its lead product candidate, CaPre\u00ae, a prescription drug derived from Krill oil, which has demonstrated the potential to reduce triglyceride levels in patients with severe hypertriglyceridemia. Acasti's commitment to scientific rigor and innovation is evident in its clinical development programs, which aim to provide safe and effective solutions for patients. The company is leveraging cutting-edge research and technology to enhance its drug formulation and delivery, positioning itself as a leader in the field of lipid management. With a vision to improve patient outcomes and quality of life, Acasti Pharma is poised to make significant contributions to cardiovascular health and wellness.",
    "industry": [
        "Pharmaceuticals",
        "Biotechnology"
    ],
    "headquarters": "Laval, Quebec, Canada",
    "founded": "2002",
    "website": "https://www.acastipharma.com",
    "ceo": "Jan D. M. V. K. R. R. D. H. M. W. A. B. H. D. G. V. P.",
    "social_media": {
        "twitter": "https://twitter.com/AcastiPharma",
        "linkedin": "https://www.linkedin.com/company/acasti-pharma-inc/"
    },
    "investor_relations": "https://ir.acastipharma.com",
    "key_executives": [
        {
            "name": "Jan D. M. V. K. R. R. D. H. M. W. A. B. H. D. G. V. P.",
            "position": "CEO"
        }
    ],
    "product_categories": [
        {
            "category": "Prescription Drugs",
            "products": [
                "CaPre\u00ae"
            ]
        }
    ],
    "seo": {
        "meta_title": "Acasti Pharma Inc. | Innovative Cardiovascular Solutions",
        "meta_description": "Explore Acasti Pharma Inc., a biopharmaceutical company focused on developing innovative treatments for cardiovascular diseases. Learn about their lead product, CaPre\u00ae.",
        "keywords": [
            "Acasti Pharma",
            "Cardiovascular Drugs",
            "Biopharmaceuticals",
            "Hypertriglyceridemia",
            "CaPre"
        ]
    },
    "faq": [
        {
            "question": "What does Acasti Pharma specialize in?",
            "answer": "Acasti Pharma specializes in the development of prescription drugs for cardiovascular diseases and lipid management."
        },
        {
            "question": "What is Acasti Pharma's lead product?",
            "answer": "Acasti Pharma's lead product is CaPre\u00ae, which is designed to reduce triglyceride levels."
        },
        {
            "question": "Where is Acasti Pharma located?",
            "answer": "Acasti Pharma is headquartered in Laval, Quebec, Canada."
        },
        {
            "question": "When was Acasti Pharma founded?",
            "answer": "Acasti Pharma was founded in 2002."
        }
    ],
    "competitors": [
        "AMRN",
        "KOD",
        "RIGL",
        "PFE"
    ],
    "related_stocks": [
        "GILD",
        "BMY",
        "JNJ",
        "MRNA"
    ]
}